| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone binding | 1.15e-05 | 265 | 133 | 10 | GO:0042393 | |
| GeneOntologyMolecularFunction | methylated histone binding | 2.37e-05 | 86 | 133 | 6 | GO:0035064 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 2.70e-05 | 88 | 133 | 6 | GO:0140034 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCA1 RNGTT ATRX ABCA13 CHD1 OLA1 RFC1 ARL15 MORC4 RGS12 NLRP3 DHX30 SEPTIN2 ARL4A ABCG1 MTIF2 GNL2 | 4.30e-05 | 839 | 133 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCA1 RNGTT ATRX ABCA13 CHD1 OLA1 RFC1 ARL15 MORC4 RGS12 NLRP3 DHX30 SEPTIN2 ARL4A ABCG1 MTIF2 GNL2 | 4.36e-05 | 840 | 133 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCA1 RNGTT ATRX ABCA13 CHD1 OLA1 RFC1 ARL15 MORC4 RGS12 NLRP3 DHX30 SEPTIN2 ARL4A ABCG1 MTIF2 GNL2 | 4.36e-05 | 840 | 133 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA1 ATRX ABCA13 CHD1 OLA1 RFC1 ARL15 MORC4 RGS12 NLRP3 DHX30 SEPTIN2 ARL4A ABCG1 MTIF2 GNL2 | 5.89e-05 | 775 | 133 | 16 | GO:0017111 |
| GeneOntologyMolecularFunction | DNA ligase (ATP) activity | 1.32e-04 | 3 | 133 | 2 | GO:0003910 | |
| GeneOntologyMolecularFunction | DNA ligase activity | 1.32e-04 | 3 | 133 | 2 | GO:0003909 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.43e-04 | 227 | 133 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA1 ATRX MYO5A ABCA13 ACSM1 CHD1 OLA1 RFC1 MORC4 NLRP3 DHX30 MSH6 ABCG1 | 2.36e-04 | 614 | 133 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | GTP binding | 3.32e-04 | 397 | 133 | 10 | GO:0005525 | |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 4.35e-04 | 5 | 133 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 7.26e-04 | 439 | 133 | 10 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 7.26e-04 | 439 | 133 | 10 | GO:0019001 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 7.51e-04 | 441 | 133 | 10 | GO:0016887 | |
| GeneOntologyMolecularFunction | ligase activity, forming phosphoric ester bonds | 9.05e-04 | 7 | 133 | 2 | GO:0016886 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 1.20e-03 | 8 | 133 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.62e-03 | 127 | 133 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.89e-03 | 262 | 133 | 7 | GO:0140097 | |
| Domain | DNA_ligase_ATP-dep_C | 1.46e-04 | 3 | 131 | 2 | IPR012309 | |
| Domain | DNA_ligase_ATP-dep_N | 1.46e-04 | 3 | 131 | 2 | IPR012308 | |
| Domain | DNA_ligase_ATP-dep_cent | 1.46e-04 | 3 | 131 | 2 | IPR012310 | |
| Domain | DNA_LIGASE_A2 | 1.46e-04 | 3 | 131 | 2 | PS00333 | |
| Domain | DNA_LIGASE_A3 | 1.46e-04 | 3 | 131 | 2 | PS50160 | |
| Domain | DNA_ligase_ATP-dep | 1.46e-04 | 3 | 131 | 2 | IPR000977 | |
| Domain | DNA_ligase_ATP-dep_CS | 1.46e-04 | 3 | 131 | 2 | IPR016059 | |
| Domain | DNA_ligase_A_M | 1.46e-04 | 3 | 131 | 2 | PF01068 | |
| Domain | - | 1.46e-04 | 3 | 131 | 2 | 1.10.3260.10 | |
| Domain | DNA_LIGASE_A1 | 1.46e-04 | 3 | 131 | 2 | PS00697 | |
| Domain | DNA_ligase_A_C | 1.46e-04 | 3 | 131 | 2 | PF04679 | |
| Domain | DNA_ligase_A_N | 1.46e-04 | 3 | 131 | 2 | PF04675 | |
| Domain | PP2A_PR55_CS | 2.90e-04 | 4 | 131 | 2 | IPR018067 | |
| Domain | PP2A_PR55 | 2.90e-04 | 4 | 131 | 2 | IPR000009 | |
| Domain | PR55_2 | 2.90e-04 | 4 | 131 | 2 | PS01025 | |
| Domain | PR55_1 | 2.90e-04 | 4 | 131 | 2 | PS01024 | |
| Domain | P-loop_NTPase | ABCA1 ATRX MYO5A ABCA13 CHD1 OLA1 RFC1 ARL15 NLRP3 DHX30 SEPTIN2 MSH6 ARL4A ABCG1 MTIF2 GNL2 | 2.96e-04 | 848 | 131 | 16 | IPR027417 |
| Domain | ZF_PHD_2 | 5.50e-04 | 95 | 131 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 5.77e-04 | 96 | 131 | 5 | PS01359 | |
| Domain | GF_recep_IV | 7.19e-04 | 6 | 131 | 2 | PF14843 | |
| Domain | GF_recep_IV | 7.19e-04 | 6 | 131 | 2 | IPR032778 | |
| Domain | - | 7.19e-04 | 6 | 131 | 2 | 1.10.600.10 | |
| Domain | - | ABCA1 ATRX ABCA13 CHD1 OLA1 RFC1 ARL15 DHX30 SEPTIN2 MSH6 ARL4A ABCG1 MTIF2 GNL2 | 7.58e-04 | 746 | 131 | 14 | 3.40.50.300 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | VRK1 KDM5A NOC2L AHCTF1 DIDO1 NCBP1 CHD1 RO60 RFC1 LCP1 DHX30 LIG1 MSH6 TAF3 FDFT1 POP1 GNL2 FADS2 CRYBG1 STIP1 PRKDC PTCD3 | 1.23e-08 | 1318 | 138 | 22 | 30463901 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EML4 GRB2 DIDO1 NCBP1 CHD1 SEC31A OLA1 RFC1 CPT1A DHX30 MSH6 TXNDC5 UBE2H EGFR TLN1 POP1 GNL2 STIP1 PRKDC CTNND1 CTSV PTCD3 | 4.32e-08 | 1415 | 138 | 22 | 28515276 |
| Pubmed | MYO5A NOC2L AHCTF1 DIDO1 NCBP1 CHD1 RFC1 LCP1 DHX30 MSH6 TLN1 POP1 GNL2 PRKDC PTCD3 | 5.62e-08 | 653 | 138 | 15 | 22586326 | |
| Pubmed | 6.11e-08 | 3 | 138 | 3 | 16874310 | ||
| Pubmed | ATRX MYO5A NOC2L AHCTF1 GPAT3 PSD3 GRB2 CHD1 TNFRSF10B DHX30 TXNDC5 EGFR FDFT1 MTIF2 TLN1 POP1 GNL2 FADS2 MAP7D2 STIP1 CTNND1 PTCD3 | 1.02e-07 | 1487 | 138 | 22 | 33957083 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | VRK1 ATRX KDM5A AHCTF1 DIDO1 NCBP1 CHD1 RFC1 MSH6 TAF3 GNL2 UHRF1 ZFP82 FOXC1 | 1.55e-07 | 608 | 138 | 14 | 36089195 |
| Pubmed | ATRX NOC2L AHCTF1 CHD1 BRMS1L RFC1 MORC4 LIG1 TAF3 UHRF1 CRYBG1 PTCD3 | 4.13e-07 | 469 | 138 | 12 | 27634302 | |
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 30610177 | ||
| Pubmed | KRT26 CLTCL1 PDSS1 KDM5A KRT27 NCBP1 CHD1 RO60 LCP1 DHX30 TXNDC5 FDFT1 POP1 OSBPL1A PRKDC KRT25 CDK3 PTCD3 | 7.78e-07 | 1153 | 138 | 18 | 29845934 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | VRK1 ATRX NOC2L NCBP1 CHD1 RO60 SEC31A OLA1 RFC1 DHX30 SEPTIN2 MSH6 TXNDC5 TLN1 GNL2 UHRF1 STIP1 PRKDC CTNND1 PTCD3 | 9.44e-07 | 1425 | 138 | 20 | 30948266 |
| Pubmed | Defective cholesterol clearance limits remyelination in the aged central nervous system. | 1.21e-06 | 6 | 138 | 3 | 29301957 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.57e-06 | 202 | 138 | 8 | 33005030 | |
| Pubmed | 1.72e-06 | 276 | 138 | 9 | 28319085 | ||
| Pubmed | 2.11e-06 | 7 | 138 | 3 | 15456754 | ||
| Pubmed | Cholesterol Accumulation in Dendritic Cells Links the Inflammasome to Acquired Immunity. | 2.11e-06 | 7 | 138 | 3 | 28479366 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYO5A NOC2L AHCTF1 ITGA6 DIDO1 NCBP1 RFC1 DHX30 SEPTIN2 MSH6 EGFR SIPA1L1 POP1 GNL2 CRYBG1 PRKDC CTNND1 PTCD3 | 2.63e-06 | 1257 | 138 | 18 | 36526897 |
| Pubmed | 3.37e-06 | 8 | 138 | 3 | 19805629 | ||
| Pubmed | Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis. | 3.37e-06 | 8 | 138 | 3 | 29588315 | |
| Pubmed | RNGTT MYO5A PSD3 GRB2 ITGA6 NCBP1 MSH6 C2CD3 TXNDC5 EGFR FDFT1 GNL2 STIP1 EIF2AK4 CTNND1 FOXC1 | 4.49e-06 | 1049 | 138 | 16 | 27880917 | |
| Pubmed | ESPN CLTCL1 ATRX MYO5A KDM5A NHSL2 NOC2L FAM47B NCBP1 NEB LCP1 LIG4 C2CD3 ANTXR1 MAP7D2 EIF2AK4 PRKDC NGLY1 FBXO15 | 4.52e-06 | 1442 | 138 | 19 | 35575683 | |
| Pubmed | VRK1 ATRX KDM5A ACSM1 GRB2 CHD1 SEC31A OLA1 MED13L SENP8 DHX30 MSH6 TAF3 UBE2H FDFT1 UQCC1 STIP1 EIF2AK4 | 5.56e-06 | 1327 | 138 | 18 | 32694731 | |
| Pubmed | 6.87e-06 | 31 | 138 | 4 | 12171929 | ||
| Pubmed | 7.19e-06 | 10 | 138 | 3 | 15314156 | ||
| Pubmed | 7.82e-06 | 179 | 138 | 7 | 19074885 | ||
| Pubmed | KDM5A EML4 AHCTF1 DIDO1 NCBP1 OLA1 RFC1 TAF3 TXNDC5 PCSK6 TLN1 POP1 GNL2 FADS2 UHRF1 EIF2AK4 CTNND1 PTCD3 | 8.67e-06 | 1371 | 138 | 18 | 36244648 | |
| Pubmed | MYO5A GPAT3 RO60 SEC31A OLA1 DHX30 MSH6 EGFR FDFT1 TLN1 CTNND1 PTCD3 | 9.18e-06 | 634 | 138 | 12 | 34591612 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NOC2L DIDO1 CHD1 RFC1 DHX30 LIG1 MSH6 TXNDC5 POP1 GNL2 FADS2 UHRF1 PRKDC CTNND1 PTCD3 | 9.74e-06 | 989 | 138 | 15 | 36424410 |
| Pubmed | 9.85e-06 | 11 | 138 | 3 | 11709713 | ||
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | 1.20e-05 | 351 | 138 | 9 | 20453000 | |
| Pubmed | 1.31e-05 | 12 | 138 | 3 | 15617563 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19836472 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 22315310 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 11971956 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 34837967 | ||
| Pubmed | Genetic variations in ABCA1/G1 associated with plasma lipid levels and risk of ischemic stroke. | 1.56e-05 | 2 | 138 | 2 | 35219812 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 15782189 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24462739 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 27702832 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 17082211 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 27449805 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 31101336 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 30864945 | ||
| Pubmed | HUNK phosphorylates EGFR to regulate breast cancer metastasis. | 1.56e-05 | 2 | 138 | 2 | 31597954 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23408463 | ||
| Pubmed | FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer. | 1.56e-05 | 2 | 138 | 2 | 25124473 | |
| Pubmed | Human EMR2, a novel EGF-TM7 molecule on chromosome 19p13.1, is closely related to CD97. | 1.56e-05 | 2 | 138 | 2 | 10903844 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 22466164 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 31507096 | ||
| Pubmed | Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1. | 1.56e-05 | 2 | 138 | 2 | 16798073 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 12032171 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23154565 | ||
| Pubmed | EGFR signaling to p120-catenin through phosphorylation at Y228. | 1.56e-05 | 2 | 138 | 2 | 14996911 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 20798376 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 21817095 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19168441 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 21266349 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23139370 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 31172973 | ||
| Pubmed | Disrupted cholesterol metabolism promotes age-related photoreceptor neurodegeneration. | 1.56e-05 | 2 | 138 | 2 | 29946056 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 22209005 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 34301174 | ||
| Pubmed | ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. | 1.56e-05 | 2 | 138 | 2 | 10878804 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 17991782 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 7527043 | ||
| Pubmed | Expression of ABC transporters during syncytialization in preeclampsia. | 1.56e-05 | 2 | 138 | 2 | 35124425 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 25225013 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 25529795 | ||
| Pubmed | Recent advances in the regulation of ABCA1 and ABCG1 by lncRNAs. | 1.56e-05 | 2 | 138 | 2 | 33545111 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19223468 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 31167810 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 16382132 | ||
| Pubmed | [Regulation of ABCA1 and ABCG1 gene expression in the intraabdominal adipose tissue]. | 1.56e-05 | 2 | 138 | 2 | 27420620 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 18490524 | ||
| Pubmed | Course of Brugia malayi infection in C57BL/6J NOS2 +/+ and -/- mice. | 1.56e-05 | 2 | 138 | 2 | 11426950 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23880356 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 17982083 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 8305738 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 16730733 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19839639 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 16000298 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 15174222 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 12828935 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 25210793 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 22952233 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24697349 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 17121837 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 21111593 | ||
| Pubmed | Efflux of sphingomyelin, cholesterol, and phosphatidylcholine by ABCG1. | 1.56e-05 | 2 | 138 | 2 | 16702602 | |
| Pubmed | Coexistence of foam cells and hypocholesterolemia in mice lacking the ABC transporters A1 and G1. | 1.56e-05 | 2 | 138 | 2 | 17967783 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19287193 | ||
| Pubmed | Grb2-related adaptor protein GRAP is a novel regulator of liver fibrosis. | 1.56e-05 | 2 | 138 | 2 | 37343720 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24661912 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 18508926 | ||
| Pubmed | Effect of insulin insufficiency on ultrastructure and function in skeletal muscle. | 1.56e-05 | 2 | 138 | 2 | 38124345 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 27239842 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23319699 | ||
| Pubmed | The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. | 1.56e-05 | 2 | 138 | 2 | 1322798 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24259669 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24500716 | ||
| Pubmed | Identification of UHRF1/2 as new N-methylpurine DNA glycosylase-interacting proteins. | 1.58e-05 | 38 | 138 | 4 | 23537643 | |
| Interaction | H3C1 interactions | SFMBT1 VRK1 ATRX KDM5A AHCTF1 GRB2 DIDO1 CHD1 BRMS1L OLA1 RFC1 NEB ESCO1 MSH6 TAF3 EGFR POP1 GNL2 UHRF1 PRKDC PTCD3 | 6.73e-07 | 901 | 136 | 21 | int:H3C1 |
| Interaction | H3-3A interactions | VRK1 ATRX KDM5A EML4 AHCTF1 DIDO1 NCBP1 CHD1 RO60 RFC1 MSH6 TAF3 UBE2H EGFR GNL2 UHRF1 PRKDC ZFP82 FOXC1 | 6.93e-07 | 749 | 136 | 19 | int:H3-3A |
| Interaction | POLD1 interactions | ATRX NCBP1 CHD1 RFC1 LIG1 TAF3 UBE2H EGFR SIPA1L1 STIP1 PRKDC CTNND1 | 3.12e-06 | 337 | 136 | 12 | int:POLD1 |
| Interaction | SERTAD4 interactions | 7.11e-06 | 19 | 136 | 4 | int:SERTAD4 | |
| Interaction | KRT81 interactions | 2.88e-05 | 53 | 136 | 5 | int:KRT81 | |
| Interaction | H3C3 interactions | VRK1 ATRX KDM5A AHCTF1 DIDO1 NCBP1 CHD1 RFC1 MSH6 GNL2 UHRF1 ZFP82 FOXC1 | 3.14e-05 | 495 | 136 | 13 | int:H3C3 |
| Interaction | PTEN interactions | SFMBT1 MAN1A1 ATRX NOC2L PSD3 GRB2 ITGA6 NCBP1 MSH6 QRFPR ARAP3 TXNDC5 ST8SIA6 EGFR POP1 CRYBG1 STIP1 PRKDC | 5.40e-05 | 929 | 136 | 18 | int:PTEN |
| Interaction | NPM1 interactions | VRK1 MYO5A NOC2L AHCTF1 GRB2 DIDO1 CHD1 RO60 RFC1 NEB DHX30 TAF3 UBE2H EGFR POP1 OSBPL1A GNL2 STIP1 PRKDC NOS2 PTCD3 | 5.47e-05 | 1201 | 136 | 21 | int:NPM1 |
| Interaction | CLNK interactions | 6.16e-05 | 32 | 136 | 4 | int:CLNK | |
| Interaction | SMC2 interactions | 6.96e-05 | 323 | 136 | 10 | int:SMC2 | |
| Interaction | H2BC21 interactions | VRK1 ATRX NOC2L AHCTF1 DIDO1 FAM47B RFC1 NEB ESCO1 MSH6 C2CD3 TLN1 UHRF1 CRYBG1 PRKDC | 7.36e-05 | 696 | 136 | 15 | int:H2BC21 |
| Interaction | RUVBL2 interactions | CLTCL1 EML4 TTI2 GRB2 NCBP1 RO60 LIG1 LIG4 UBE2H EGFR FDFT1 STIP1 PRKDC NOS2 | 7.40e-05 | 616 | 136 | 14 | int:RUVBL2 |
| Interaction | LRRC31 interactions | 7.74e-05 | 205 | 136 | 8 | int:LRRC31 | |
| GeneFamily | DNA ligases|Nucleotide excision repair | 7.49e-05 | 3 | 91 | 2 | 1247 | |
| GeneFamily | CD molecules|Adhesion G protein-coupled receptors, subfamily E | 2.48e-04 | 5 | 91 | 2 | 915 | |
| GeneFamily | Keratins, type I | 3.69e-04 | 28 | 91 | 3 | 608 | |
| GeneFamily | PHD finger proteins | 1.10e-03 | 90 | 91 | 4 | 88 | |
| GeneFamily | ATP binding cassette subfamily A | 2.19e-03 | 14 | 91 | 2 | 805 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 2.52e-03 | 15 | 91 | 2 | 696 | |
| Coexpression | SRC_UP.V1_DN | 2.72e-07 | 170 | 136 | 9 | M2713 | |
| Coexpression | GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN | 4.72e-06 | 180 | 136 | 8 | M8906 | |
| Coexpression | VEGF_A_UP.V1_DN | 7.87e-06 | 193 | 136 | 8 | M2675 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SFMBT1 VRK1 RNGTT ATRX KDM5A AHCTF1 PSD3 ITGA6 CHD1 MED13L MSH6 C2CD3 EGFR MTIF2 SIPA1L1 SERPINB2 | 9.85e-06 | 856 | 136 | 16 | M4500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | RNGTT ATRX KDM5A DIDO1 LCP1 ZNF250 LIG1 TAF3 MTIF2 SIPA1L1 POP1 GNL2 PAK3 MAP7D2 EIF2AK4 | 5.47e-06 | 595 | 134 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | SFMBT1 ATRX KDM5A AHCTF1 DIDO1 CHD1 OLA1 RFC1 SENP8 DHX30 C2CD3 RSAD2 TXNDC5 INMT MAP7D2 CRYBG1 MAPK4 | 1.21e-05 | 801 | 134 | 17 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | MYO5A PSD3 NCBP1 CHD1 RO60 BRMS1L FOCAD EGFR OSBPL1A PAK3 ANTXR1 ZFP82 | 5.19e-05 | 478 | 134 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK---L2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.27e-07 | 200 | 139 | 8 | 6ebdae4438bc64c6620416f64a7e22fbca2664bf | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.27e-07 | 200 | 139 | 8 | 081ca331b56f85167acfc73af9d2e91f398f8c4d | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.27e-07 | 200 | 139 | 8 | 66e2f3e2e9063f17b47621120eb6009405f69e7e | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.27e-07 | 200 | 139 | 8 | 940892bea41fde567f138a896d151acccef03a6a | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac-Erythrophagocytic_macrophages|bone_marrow / Manually curated celltypes from each tissue | 1.60e-06 | 180 | 139 | 7 | daf69a548ed7c6f285a6adcff00f99aa22f9d6a5 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.85e-06 | 184 | 139 | 7 | 1c56378b3888c46258d446b47de4d6282fe74b0d | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.85e-06 | 184 | 139 | 7 | a45980306c4e697a2703bed72a7b48fb23d942f4 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.99e-06 | 186 | 139 | 7 | 055cc23c4db9aad2d6c62e62c8e58bfe5047c6b1 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.13e-06 | 188 | 139 | 7 | 3be2d50148daa4eddddc2c7f269f45c97f7e4931 | |
| ToppCell | RA-08._Macrophage|World / Chamber and Cluster_Paper | 2.54e-06 | 193 | 139 | 7 | 5fd22db1825d105709fcc0aa4955c99a117e3c82 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.54e-06 | 193 | 139 | 7 | 01c71aa48875b5ad6c50cc810a72862e72f26ad0 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.54e-06 | 193 | 139 | 7 | 84d1c1b7d3a1cb80f175527e3c89a2c3da7657f7 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.62e-06 | 194 | 139 | 7 | 32ba2cf9b8726bc3c6e9dc24b54d22ff188bb12b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-06 | 194 | 139 | 7 | ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.62e-06 | 194 | 139 | 7 | 53a5e8863d79a052dff0758f389be5ac3883c721 | |
| ToppCell | 3'_v3-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Lung / Manually curated celltypes from each tissue | 1.24e-05 | 163 | 139 | 6 | 47300dec94dc66e965bf71fafff0a9fd24fae968 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.43e-05 | 167 | 139 | 6 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-05 | 171 | 139 | 6 | b520d4d5620cac08315e4cbb7e796c5e9e233060 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-05 | 175 | 139 | 6 | 77c16e615c0fb9c83f29d7e0a547be72635fac81 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.05e-05 | 178 | 139 | 6 | aa9f68a66e292f331faef881bbd0d028f0f2b0c5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-05 | 179 | 139 | 6 | e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.11e-05 | 179 | 139 | 6 | 98c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-4|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 2.18e-05 | 180 | 139 | 6 | 886ebaf9cf8992e8dd13fca799a1d1a2a9ce73d8 | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Intermediate_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.32e-05 | 182 | 139 | 6 | fec1caf867b1dc87b24504d895ee1a27df78062e | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 2.39e-05 | 183 | 139 | 6 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-05 | 184 | 139 | 6 | d1ea2b60fb1ca1a0b809d131310c43903a9e84ce | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.47e-05 | 184 | 139 | 6 | 30fddbc9696476d4d7f08e53f84ea994a4ed873a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-05 | 184 | 139 | 6 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.47e-05 | 184 | 139 | 6 | 96926efa220f03d0787322c9519bb9e8f64f74d0 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.54e-05 | 185 | 139 | 6 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.54e-05 | 185 | 139 | 6 | 3be9e05b929ac4d956b1d53284072f668a6c1959 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-lymphatic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.54e-05 | 185 | 139 | 6 | c3dd64a726cb8a1fe048683c266b7532a714a52e | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue | 2.70e-05 | 187 | 139 | 6 | 3c10b8501226c69d71bcd99dc1c064a3c2154f87 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.78e-05 | 188 | 139 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-05 | 188 | 139 | 6 | 58ccb31cdf43167872ef0fc737e6f9c51ee2e060 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 188 | 139 | 6 | 8cc927b4c51d982fdafa04dc7393617ad9bb220e | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.87e-05 | 189 | 139 | 6 | 0d18ea72bd58d32a8ab9a61cf97f5786642f804b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-05 | 189 | 139 | 6 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-05 | 189 | 139 | 6 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.95e-05 | 190 | 139 | 6 | ad297172a74a80ed5c10f921e15efd1da0fd2d6b | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.95e-05 | 190 | 139 | 6 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-05 | 190 | 139 | 6 | b3bccf4dd95e986db3cee324a6737f5fcc22e8e5 | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 2.95e-05 | 190 | 139 | 6 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | COPD-Myeloid-cDC2|COPD / Disease state, Lineage and Cell class | 3.04e-05 | 191 | 139 | 6 | 2af6e4a6bd1f2193ece2131c3b7d976dd23a6966 | |
| ToppCell | COPD-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 3.04e-05 | 191 | 139 | 6 | 4e4887175200a57e1b041f2f131e3df774df3509 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.04e-05 | 191 | 139 | 6 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 3.13e-05 | 192 | 139 | 6 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.13e-05 | 192 | 139 | 6 | 30cefa0990ba1f379f350bfbf994a78db145075e | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 3.13e-05 | 192 | 139 | 6 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.13e-05 | 192 | 139 | 6 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-05 | 192 | 139 | 6 | f7e7491426bbd6ed29a465b58bf67acb93dbb90a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 192 | 139 | 6 | 9ae05db5bfb8b9d3935c0328e6f2d489d2b1ebfd | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor | 3.13e-05 | 192 | 139 | 6 | 733491e932350e3c216a626cc49c3cd3fe970a82 | |
| ToppCell | Endothelial|World / shred on cell class and cell subclass (v4) | 3.13e-05 | 192 | 139 | 6 | 2b13cca5c4b58628dbbbb356859632dba66d43f9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 192 | 139 | 6 | a116db7dec495e5a0ba9c7537057cd1e567d7885 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 192 | 139 | 6 | 66defad13bd8e79319741e43ddb056841710b1d7 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 192 | 139 | 6 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.22e-05 | 193 | 139 | 6 | 9f9eb241b0b82a6f12de6921c3acf6fed7cf65bb | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.22e-05 | 193 | 139 | 6 | d338a7c0585b69947c37f44aa0381619493e31ea | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 193 | 139 | 6 | e4b440d50ae7391b26924778be6d9d53e0692449 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 193 | 139 | 6 | e523dc5751f6fdcd4fc1a62b1eecd43f6ae79da9 | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 3.22e-05 | 193 | 139 | 6 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | Control-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 3.22e-05 | 193 | 139 | 6 | 3479c01aaae7afd7e02d00e0cb21951c0106a0fd | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 193 | 139 | 6 | 1772f2ac217727de63c4a9303881b3a19a6bb0f0 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.22e-05 | 193 | 139 | 6 | 72d20ee257149b238016b44d183ce3fc24b8f621 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.32e-05 | 194 | 139 | 6 | 3043f6230fa723037c8cf7123f611ae847b39fd4 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.32e-05 | 194 | 139 | 6 | 3c31ac44e8cf4eca3ba7b8bfc05ad3e96a970956 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.32e-05 | 194 | 139 | 6 | efd5efed060edb7f24d59600981bb60ec28ac2ef | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.32e-05 | 194 | 139 | 6 | 28571cf24b8a1d0ffb716167b977d420868cc874 | |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 3.32e-05 | 194 | 139 | 6 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| ToppCell | RA-08._Macrophage|RA / Chamber and Cluster_Paper | 3.32e-05 | 194 | 139 | 6 | ac26e5c71d5069622de72fa25a9c920887ac2c19 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_dendritic_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.42e-05 | 195 | 139 | 6 | 4387e27d2288fb46a9ed110464542a4aea402358 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.42e-05 | 195 | 139 | 6 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 3.42e-05 | 195 | 139 | 6 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 3.42e-05 | 195 | 139 | 6 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | 3.42e-05 | 195 | 139 | 6 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.42e-05 | 195 | 139 | 6 | 3826bfafe85f8aa9a508202ceb2b02e81b090498 | |
| ToppCell | PCW_07-8.5-Endothelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.42e-05 | 195 | 139 | 6 | f2cc94d5e1652203ca38bea57f37d3deec73ef04 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.42e-05 | 195 | 139 | 6 | 31353269591c9eee84872838e91995d4a035da46 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.52e-05 | 196 | 139 | 6 | 2a2a93b89dcb98043cb1f8b422ac8c55e2edc37b | |
| ToppCell | PCW_13-14-Endothelial|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.52e-05 | 196 | 139 | 6 | 7286de29a34e13834cd6347c67a1443897fa4ade | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.52e-05 | 196 | 139 | 6 | b826dce5b3daa8eb3d4a530b9564de58d9ce3767 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.52e-05 | 196 | 139 | 6 | 29ed8b1c4cd730db8632fde6eece404f1883a86d | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Neutrophils|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.52e-05 | 196 | 139 | 6 | 376c5a459a484205fbb0db34936e4a6146d1f622 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.52e-05 | 196 | 139 | 6 | c65b8c7ea34a21897c390e6fb42ee8ca41e9c976 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.52e-05 | 196 | 139 | 6 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature_venous_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.52e-05 | 196 | 139 | 6 | 81278e696d823744267d6315c4d42799c4ea0b2c | |
| ToppCell | mild_COVID-19_(asymptomatic)|World / disease group, cell group and cell class (v2) | 3.52e-05 | 196 | 139 | 6 | 8cb3dcb3e5732f4bb060c87ca339b8997a1a8cd4 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.52e-05 | 196 | 139 | 6 | 9ed96085f0acce07bf2f8d4cc212cc50e613be0c | |
| ToppCell | PCW_10-12-Endothelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.52e-05 | 196 | 139 | 6 | 2c60dcf9132ee156f25b349e2ac5313709def4f6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-05 | 197 | 139 | 6 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.62e-05 | 197 | 139 | 6 | 4e9221cb02122aed2981c3c9157e847a3710e323 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-NK_CD56bright|ICU-SEP / Disease, condition lineage and cell class | 3.62e-05 | 197 | 139 | 6 | c187e3fc2160b0165eb039cf09a6e621016068b7 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-05 | 197 | 139 | 6 | d568354aff89ac84dd06360f19100ef578a041ed | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-05 | 197 | 139 | 6 | 0c059476a8cdc6ac71a01d9c414295177f45f8de | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-05 | 197 | 139 | 6 | 1eb9ff8467118b943b5d443cb996168e1e1206b5 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_cycling-endo_proliferating3_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.62e-05 | 197 | 139 | 6 | aedc1e3ed6b558bf2f7649919f43049f8348ab85 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.72e-05 | 198 | 139 | 6 | eac26ed95b4a4343a5dfe1fbecef9374e5947884 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.72e-05 | 198 | 139 | 6 | 4b6767bd6fd4bd43eed18fd4a34c20923fa795da | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 3.72e-05 | 198 | 139 | 6 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| Drug | Meropenem [96036-03-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | MAN1A1 EML4 ITGA6 MANEA TNFRSF10B LCP1 RGS12 AP4E1 MSH6 LIG4 EGFR CDK3 | 2.11e-09 | 197 | 134 | 12 | 7180_UP |
| Drug | Bromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 2.60e-06 | 197 | 134 | 9 | 1507_DN | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.56e-06 | 239 | 134 | 9 | EFO_0008317, EFO_0020945 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.74e-06 | 86 | 134 | 6 | EFO_0008595, EFO_0020945 | |
| Disease | very low density lipoprotein cholesterol measurement | 3.12e-06 | 260 | 134 | 9 | EFO_0008317 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 3.53e-06 | 264 | 134 | 9 | EFO_0008317, EFO_0020944 | |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 5.20e-06 | 96 | 134 | 6 | EFO_0004530, EFO_0008317, EFO_0008596 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.61e-05 | 243 | 134 | 8 | EFO_0004612, EFO_0020944 | |
| Disease | autosomal recessive nonsyndromic deafness 114 (implicated_via_orthology) | 2.05e-05 | 2 | 134 | 2 | DOID:0111642 (implicated_via_orthology) | |
| Disease | triacylglycerol 56:8 measurement | 2.14e-05 | 36 | 134 | 4 | EFO_0010435 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 3.79e-05 | 274 | 134 | 8 | EFO_0004530, EFO_0004612 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 3.99e-05 | 276 | 134 | 8 | EFO_0004612, EFO_0020943 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 6.56e-05 | 150 | 134 | 6 | EFO_0004611, EFO_0020947 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 7.32e-05 | 153 | 134 | 6 | EFO_0004611, EFO_0020944 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 7.48e-05 | 95 | 134 | 5 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 7.89e-05 | 225 | 134 | 7 | EFO_0008317, EFO_0020947 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 7.96e-05 | 50 | 134 | 4 | EFO_0022303 | |
| Disease | cholesterol to total lipids in small HDL percentage | 8.61e-05 | 51 | 134 | 4 | EFO_0022240 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 8.61e-05 | 51 | 134 | 4 | EFO_0022242 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 1.14e-04 | 321 | 134 | 8 | EFO_0004612, EFO_0004639 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 1.15e-04 | 166 | 134 | 6 | EFO_0004530, EFO_0004611 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.26e-04 | 106 | 134 | 5 | EFO_0008317, EFO_0008596 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 1.43e-04 | 58 | 134 | 4 | EFO_0022338 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.43e-04 | 109 | 134 | 5 | EFO_0004639, EFO_0008317, EFO_0008596 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.50e-04 | 110 | 134 | 5 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.50e-04 | 110 | 134 | 5 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 1.56e-04 | 111 | 134 | 5 | EFO_0004530, EFO_0008595 | |
| Disease | fatty acid measurement | 1.77e-04 | 436 | 134 | 9 | EFO_0005110 | |
| Disease | triglycerides in medium LDL measurement | 1.85e-04 | 62 | 134 | 4 | EFO_0022322 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 1.97e-04 | 63 | 134 | 4 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 1.97e-04 | 63 | 134 | 4 | EFO_0022239 | |
| Disease | phosphatidylcholine (16:0/22:5n3, 18:1/20:4) measurement | 2.03e-04 | 5 | 134 | 2 | EFO_0800467 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 2.08e-04 | 118 | 134 | 5 | EFO_0010119 | |
| Disease | triglycerides in small LDL measurement | 2.22e-04 | 65 | 134 | 4 | EFO_0022323 | |
| Disease | Colorectal Neoplasms | 2.84e-04 | 277 | 134 | 7 | C0009404 | |
| Disease | esterified cholesterol measurement | 3.03e-04 | 128 | 134 | 5 | EFO_0008589 | |
| Disease | thioredoxin domain-containing protein 5 measurement | 3.03e-04 | 6 | 134 | 2 | EFO_0802128 | |
| Disease | triacylglycerol 56:7 measurement | 3.07e-04 | 29 | 134 | 3 | EFO_0010434 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.15e-04 | 200 | 134 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | Colorectal Carcinoma | ABCA1 ABCA13 SCG5 CHD1 LIG1 MSH6 ABCG1 ARAP3 EGFR FADS2 MMP11 | 3.73e-04 | 702 | 134 | 11 | C0009402 |
| Disease | free cholesterol to total lipids in small VLDL percentage | 3.85e-04 | 75 | 134 | 4 | EFO_0022287 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 4.14e-04 | 137 | 134 | 5 | EFO_0004611, EFO_0008591 | |
| Disease | suberic acid measurement | 4.24e-04 | 7 | 134 | 2 | EFO_0010534 | |
| Disease | Profound Mental Retardation | 4.43e-04 | 139 | 134 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 4.43e-04 | 139 | 134 | 5 | C0025363 | |
| Disease | Mental deficiency | 4.43e-04 | 139 | 134 | 5 | C0917816 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 4.47e-04 | 78 | 134 | 4 | EFO_0022187 | |
| Disease | triglyceride measurement, physical activity | 4.94e-04 | 34 | 134 | 3 | EFO_0003940, EFO_0004530 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 5.20e-04 | 144 | 134 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 5.21e-04 | 220 | 134 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | free cholesterol in small HDL measurement | 5.39e-04 | 35 | 134 | 3 | EFO_0022270 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 5.47e-04 | 222 | 134 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | triglyceride measurement, phospholipid measurement | 5.54e-04 | 146 | 134 | 5 | EFO_0004530, EFO_0004639 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 5.73e-04 | 224 | 134 | 6 | EFO_0004530, EFO_0008317 | |
| Disease | diabetic nephropathy | 6.26e-04 | 150 | 134 | 5 | EFO_0000401 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 6.43e-04 | 229 | 134 | 6 | EFO_0004639, EFO_0008317 | |
| Disease | nasopharyngeal neoplasm | 6.45e-04 | 151 | 134 | 5 | EFO_0004252 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 6.85e-04 | 153 | 134 | 5 | EFO_0004611, EFO_0020946 | |
| Disease | Abnormality of the face | 7.22e-04 | 9 | 134 | 2 | C4025871 | |
| Disease | Arthritis, Collagen-Induced | 8.00e-04 | 40 | 134 | 3 | C0971858 | |
| Disease | Arthritis, Experimental | 8.00e-04 | 40 | 134 | 3 | C0993582 | |
| Disease | Arthritis, Adjuvant-Induced | 8.00e-04 | 40 | 134 | 3 | C0003865 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 8.03e-04 | 239 | 134 | 6 | EFO_0010934 | |
| Disease | Human papillomavirus infectious disease (is_marker_for) | 8.99e-04 | 10 | 134 | 2 | DOID:11166 (is_marker_for) | |
| Disease | systolic blood pressure, self reported educational attainment | 8.99e-04 | 10 | 134 | 2 | EFO_0004784, EFO_0006335 | |
| Disease | oleoyl-linoleoyl-glycerol (18:1/18:2) [2] measurement | 8.99e-04 | 10 | 134 | 2 | EFO_0800333 | |
| Disease | Adenocarcinoma of large intestine | 9.78e-04 | 96 | 134 | 4 | C1319315 | |
| Disease | triacylglycerol 56:6 measurement | 9.90e-04 | 43 | 134 | 3 | EFO_0010433 | |
| Disease | free cholesterol to total lipids in IDL percentage | 9.90e-04 | 43 | 134 | 3 | EFO_0022278 | |
| Disease | coronary artery calcification | 1.08e-03 | 450 | 134 | 8 | EFO_0004723 | |
| Disease | phosphatidylcholine 32:0 measurement | 1.10e-03 | 11 | 134 | 2 | EFO_0010372 | |
| Disease | level of Sterol ester (27:1/20:5) in blood serum | 1.10e-03 | 11 | 134 | 2 | OBA_2045197 | |
| Disease | oleoyl-linoleoyl-glycerol (18:1/18:2) [1] measurement | 1.10e-03 | 11 | 134 | 2 | EFO_0800332 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 1.10e-03 | 99 | 134 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | triglyceride measurement, alcohol drinking | 1.10e-03 | 99 | 134 | 4 | EFO_0004329, EFO_0004530 | |
| Disease | saturated fatty acids measurement | 1.13e-03 | 45 | 134 | 3 | EFO_0022304 | |
| Disease | cholesteryl ester measurement | 1.17e-03 | 257 | 134 | 6 | EFO_0010351 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 1.18e-03 | 101 | 134 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | triacylglycerol 54:4 measurement | 1.21e-03 | 46 | 134 | 3 | EFO_0010422 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 1.23e-03 | 102 | 134 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | Malignant neoplasm of breast | UTS2R MANEA OLA1 CPT1A MSH6 ARAP3 EGFR SIPA1L1 POP1 SERPINB2 MAP7D2 UQCC1 NOS2 | 1.24e-03 | 1074 | 134 | 13 | C0006142 |
| Disease | Pathological accumulation of air in tissues | 1.31e-03 | 12 | 134 | 2 | C0013990 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.31e-03 | 12 | 134 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | arachidonoylcarnitine (C20:4) measurement | 1.31e-03 | 12 | 134 | 2 | EFO_0800544 | |
| Disease | Kidney Failure, Chronic | 1.36e-03 | 48 | 134 | 3 | C0022661 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 1.45e-03 | 49 | 134 | 3 | EFO_0022256 | |
| Disease | dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement | 1.55e-03 | 13 | 134 | 2 | EFO_0800547 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.62e-03 | 110 | 134 | 4 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol in large LDL measurement | 1.63e-03 | 51 | 134 | 3 | EFO_0022176 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 1.63e-03 | 51 | 134 | 3 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 1.63e-03 | 51 | 134 | 3 | EFO_0022302 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 1.63e-03 | 51 | 134 | 3 | EFO_0022285 | |
| Disease | linoleic acid measurement | 1.63e-03 | 186 | 134 | 5 | EFO_0006807 | |
| Disease | Saldino-Noonan Syndrome | 1.80e-03 | 14 | 134 | 2 | C0036069 | |
| Disease | Asbestosis | 1.80e-03 | 14 | 134 | 2 | C0003949 | |
| Disease | Pulmonary Fibrosis - from Asbestos Exposure | 1.80e-03 | 14 | 134 | 2 | C2930617 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 1.82e-03 | 53 | 134 | 3 | EFO_0022340 | |
| Disease | triglycerides in HDL measurement | 1.82e-03 | 53 | 134 | 3 | EFO_0022317 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 1.82e-03 | 53 | 134 | 3 | EFO_0022286 | |
| Disease | antihyperlipidemic drug use measurement | 1.90e-03 | 115 | 134 | 4 | EFO_0803367 | |
| Disease | Peripheral Nervous System Diseases | 1.92e-03 | 54 | 134 | 3 | C4721453 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.01e-03 | 195 | 134 | 5 | DOID:1574 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VLKAWLDITRGKEPY | 146 | Q7Z4L5 | |
| KLWKVSERDKRPEGY | 116 | Q00005 | |
| KLWKITERDKRPEGY | 116 | Q9Y2T4 | |
| YKPTKGWEERTKKIG | 406 | Q8NEF3 | |
| WPLEGAKVYLGIRKK | 1271 | Q8WWN8 | |
| KKYFELEPLARGKRW | 156 | Q9NXU5 | |
| SSPRKWYSPIKGKLD | 441 | Q9H6X2 | |
| KGKLDALWVLLRKGY | 451 | Q9H6X2 | |
| LPYKTGKKGDVWRLG | 471 | Q9P2K8 | |
| VPEGPWWRKKGYKTL | 86 | P45844 | |
| REQYGKWSKGIRKLK | 786 | Q9UHX3 | |
| FLDLPKSVDWRKKGY | 111 | O60911 | |
| KSVDWREKGYVTPVK | 61 | Q5NE16 | |
| RYGVWYLKPKLGKKL | 311 | A6NHR8 | |
| WYKAELRGVEGFIPK | 36 | Q8TC17 | |
| WYKAELRGVEGFIPK | 36 | Q13588 | |
| EWAIRKLGLVKYGEK | 2026 | O95477 | |
| VGGQEKLRPLWKSYT | 76 | P40617 | |
| VGLGPRLQWYLKLKS | 211 | P50416 | |
| ELWAYGISKGKRAKL | 836 | Q86UQ4 | |
| DYPGLGKWNKKLLYE | 156 | P05408 | |
| KGKGKVRTYWLLGER | 1041 | P16066 | |
| IKWPKSVEVEGYGSK | 91 | Q7L2E3 | |
| LVRKKKKIPGYRWGD | 26 | Q8N7E2 | |
| KKIPGYRWGDIKINI | 31 | Q8N7E2 | |
| KEPGEIQYLIKWKGW | 311 | O14646 | |
| LKLEGIKKLWGKEGY | 701 | Q9UPM8 | |
| KIGYELWIKKRVGDG | 236 | Q96P65 | |
| KIKEWVDKYDPGALV | 246 | Q9NTK5 | |
| LEQKIKGWYEKCEPG | 111 | Q7Z3Y9 | |
| IYKNPVTWLKDLLGG | 1741 | Q8N7Z5 | |
| IDLGWKPKYGRFDVV | 291 | P35228 | |
| LGEWQPIEYGKKKLK | 241 | O95864 | |
| KYLIARGKLDWAEGP | 826 | Q8N612 | |
| RKAYGPKVDIWSLGI | 451 | O75914 | |
| LEVIPKIWKDSKEYG | 506 | Q96EY7 | |
| LKLWLEKFVYKGGLT | 191 | Q9HBL6 | |
| EIYKKGQSKRIWGEL | 196 | Q13823 | |
| RIGKWFVRPYEKDEK | 141 | Q71F56 | |
| SLPWVGKELYEKKDA | 176 | Q09161 | |
| KPLLYEIGWGKKLSY | 361 | Q96IV0 | |
| GKYKPGRCDDILKWK | 446 | O60942 | |
| LELKKKYSWGAPLAI | 141 | Q96T17 | |
| YRLLVTKKEEGPWKS | 66 | P46199 | |
| REELEKWLKKEPGAY | 91 | O95050 | |
| KVGSPSYLDKLLWRD | 431 | P31152 | |
| KLRTLGYDESKLAPW | 826 | B1AK53 | |
| WSRYVKKLGDFAKPE | 236 | P37268 | |
| DKEKIREKYGPEWAR | 46 | Q9H425 | |
| KLWKKYGSRFPQDDL | 181 | P50135 | |
| PEKQGKLKEWSLILY | 616 | P29122 | |
| LKEGKPYLVLGLLWQ | 216 | P13796 | |
| GPKGVINDWRKFKLE | 21 | P20941 | |
| LKLVEYKGQKWVDGG | 151 | P41247 | |
| WYFEPKLGKKLRSDE | 551 | Q8NA70 | |
| DLEQKIKGWYEKFGP | 111 | Q7Z3Y8 | |
| DLEQKIKGWYEKFGP | 106 | Q7Z3Z0 | |
| GKWLLYLVKVESKGL | 901 | P23229 | |
| GWVSKRLLKPYTGSK | 141 | P52701 | |
| GSIYPKLKFWGKSVE | 671 | Q9BXW6 | |
| WYKAELNGKDGFIPK | 36 | P62993 | |
| PLWGKLRVDIKAYLG | 241 | Q9Y3T9 | |
| EKKWSKVGSRLGYLP | 136 | P29375 | |
| KPGLYLELTRKWSEK | 431 | Q5SRI9 | |
| KKWGYCLGERPTVKS | 216 | Q99575 | |
| YKGSFPKWTRKGLEE | 236 | Q00526 | |
| VYKGLWIPEGEKVKI | 726 | P00533 | |
| DKPLIYKGEGKWLRN | 2066 | P46100 | |
| WRDIAKPYKTRNDGK | 361 | Q01638 | |
| FRGKPLPKVTWYKDG | 631 | Q8N9C0 | |
| KELLIKRSGITGWYP | 1326 | Q4AC94 | |
| AGEGVQRKKPLYWDL | 326 | Q99704 | |
| SIYKPDKRGEGWLKI | 436 | P49917 | |
| DKRGEGWLKIKPEYV | 441 | P49917 | |
| KVFDGWILKGEKFPS | 111 | P24387 | |
| PWDGGLKRAKVKDIF | 401 | Q53EU6 | |
| KYTDPFKLGWRDLKG | 91 | Q5T2R2 | |
| LGWAIILKEKGGKEY | 196 | Q8NCQ5 | |
| RDDKKPGKGSYWTLD | 141 | Q12948 | |
| LLDKKEYRKPIDWGA | 151 | P22914 | |
| LYSGWLRKSPPEKKL | 41 | Q2WGN9 | |
| SNPKAEVRYKIRGKW | 146 | Q4KMG0 | |
| SRWYGKRKVEGLPYK | 66 | Q8N1D5 | |
| ARKKYGPKIDVWSIG | 236 | P57058 | |
| RIAPKTVWDYVGKLK | 1096 | Q9BTC0 | |
| KGYAWGLNELKPISK | 211 | P33908 | |
| VWFKRPDGSKSKLYI | 296 | Q5PSV4 | |
| VGWKKERILAEYPDG | 651 | Q5FWF5 | |
| IEKLWKRDEGGTGKY | 736 | Q8WYP5 | |
| PEKLKLEWAYGYRGK | 256 | Q9HC35 | |
| KKTWKPFIGYDSLRI | 176 | Q8NEL9 | |
| MKVLRGIWVAYEKPG | 1266 | Q9Y4K1 | |
| WSLKSDGRIYSKLKP | 1671 | Q9Y4K1 | |
| NWLKLKKDYLDGVGD | 741 | P18858 | |
| GYKELRKPLEKEGWK | 831 | O60716 | |
| LPEFKKKAVWTRAYG | 1786 | Q5VW36 | |
| KEYLKGLCSPELWKE | 66 | Q9P2P1 | |
| GKWKTPFEKKLNGLY | 206 | P05120 | |
| RDLYEKAKRDEPKWG | 81 | Q96P20 | |
| RGRLYWKFDPVKVKA | 451 | P24347 | |
| KETGRETKYPWKEFL | 566 | Q5VWG9 | |
| DLKPDWGKGYSRKAA | 66 | P31948 | |
| KKAYLEWPKDRRKCG | 751 | Q9BXR5 | |
| KVRSKWLREKPYNGG | 1056 | Q9UPZ6 | |
| RGGKYIWSKADLKLD | 346 | Q8WXG1 | |
| VKIWRQEGPLALYKG | 256 | Q6PIV7 | |
| KRKLLGWKEPGEAFV | 1121 | Q5HYW2 | |
| WVDKYKPTSLKTIIG | 586 | P35251 | |
| SSKYKWILGEEPVEK | 561 | Q8TE76 | |
| RQGATSKYLIGWKKP | 1476 | O43166 | |
| SKYLIGWKKPEGTIN | 1481 | O43166 | |
| PKYLKDLALFWRTKG | 301 | P61647 | |
| RWSKDGKELRDGPKY | 86 | A0A087WV53 | |
| YKTGHGLRGKLKWRP | 331 | P10155 | |
| VREEYKRWITGKTKP | 851 | Q14246 | |
| LDYWAQKEKEGKRGP | 56 | Q08AH1 | |
| KKVGYTPDWIFLLRG | 506 | P53675 | |
| RGEDPWVLDRKGAKK | 76 | P15622 | |
| YEGGVWKVRVDLPDK | 46 | P62256 | |
| GGLYEGKGWLKPKLD | 111 | O14924 | |
| ILGLLKPDLYKESWK | 206 | Q6NXR4 | |
| PKKGIWLEAGKALDY | 56 | Q9Y490 | |
| KKPGVYTRITRLKGW | 716 | Q7Z410 | |
| TPVKELVSLKWKRYG | 351 | Q9H1D0 | |
| LWPEKAALKVLGKDY | 196 | A8MX80 | |
| TPAYITKKRGEWKDL | 191 | Q96LD8 | |
| LWKKVLPYLKGICSG | 236 | O14763 | |
| GFTGPLKYSKWKIKI | 101 | Q9NVA1 | |
| EAKLYGKKRKWGGTV | 1736 | O43151 | |
| EEWALLGPSQKKLYR | 16 | Q8N972 | |
| RTRKLKYLGVPKYWG | 101 | Q99986 | |
| SGEVRTGKWKVPTYK | 511 | P78527 | |
| VVKYWPEKGKSGFLV | 561 | Q96T88 | |
| PEKGKSGFLVWRYLL | 566 | Q96T88 | |
| RPKGYRKLLALGTWL | 161 | Q9UKP6 | |
| GKEPWKVVRKGRRQY | 61 | Q8N141 | |
| GYPTLLWFRDGKKVD | 261 | Q8NBS9 | |
| IEAKGKKVRGRLYPW | 246 | Q15019 | |
| GSYLWLQLEGSKKPI | 411 | Q9UHJ3 | |
| RIRSKWLKEKPYNGG | 1021 | Q9C0I4 | |
| KLIWGPYKMDSKGDV | 71 | O94979 | |
| PRGKRGWKTFYAVLK | 806 | Q9NYI0 | |
| KVLWRYKGKKPATLG | 341 | P0DTE5 | |
| VWKSAELLKDYKPGD | 21 | Q9Y4I1 | |
| KWRSYKGELFDKTPV | 681 | Q6NSJ0 | |
| AGWEEEKKKGYDLRP | 1786 | P20929 |